Detalhe da pesquisa
1.
Sterile inflammation via TRPM8 RNA-dependent TLR3-NF-kB/IRF3 activation promotes antitumor immunity in prostate cancer.
EMBO J
; 43(5): 780-805, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38316991
2.
Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
N Engl J Med
; 384(9): 829-841, 2021 03 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33657295
3.
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study.
Cancer Immunol Immunother
; 73(6): 106, 2024 Apr 18.
Artigo
Inglês
| MEDLINE | ID: mdl-38634928
4.
Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study.
Cancer Immunol Immunother
; 72(9): 2961-2970, 2023 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-37248424
5.
The role of the caregiver in older patients with advanced prostate cancer: results from the ADHERE Prospective Study of the Meet-URO network.
Support Care Cancer
; 31(7): 425, 2023 Jun 26.
Artigo
Inglês
| MEDLINE | ID: mdl-37358628
6.
Adherence to Oral Treatments in Older Patients with Advanced Prostate Cancer, the ADHERE Study: A Prospective Trial of the Meet-URO Network.
Oncologist
; 27(12): e949-e956, 2022 Dec 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35920559
7.
Circulating tumor cell gene expression and plasma AR gene copy number as biomarkers for castration-resistant prostate cancer patients treated with cabazitaxel.
BMC Med
; 20(1): 48, 2022 01 31.
Artigo
Inglês
| MEDLINE | ID: mdl-35101049
8.
The prognostic value of the previous nephrectomy in pretreated metastatic renal cell carcinoma receiving immunotherapy: a sub-analysis of the Meet-URO 15 study.
J Transl Med
; 20(1): 435, 2022 09 30.
Artigo
Inglês
| MEDLINE | ID: mdl-36180954
9.
Renal cell carcinoma: the population, real world, and cost-of-illness.
BMC Urol
; 22(1): 206, 2022 Dec 19.
Artigo
Inglês
| MEDLINE | ID: mdl-36536329
10.
To Transplant or Not to Transplant During the SARS-CoV-2 Pandemic? That Is the Question.
Oncologist
; 26(2): e336-e337, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33044758
11.
Prognostic Role of Circulating Tumor Cells in Metastatic Renal Cell Carcinoma: A Large, Multicenter, Prospective Trial.
Oncologist
; 26(9): 740-750, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34077597
12.
Safety and Efficacy of Tivozanib in First-Line mRCC: A Multicenter Compassionate-Use Study (Meet-Uro 16).
Oncology
; 99(12): 747-755, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34583356
13.
Fatal hyperprogression induced by nivolumab in metastatic renal cell carcinoma with sarcomatoid features: a case report.
Anticancer Drugs
; 32(2): 222-225, 2021 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32868643
14.
An Italian, multicenter, real-world, retrospective study of first-line pazopanib in unselected metastatic renal-cell carcinoma patients: the 'Pamerit' study.
Jpn J Clin Oncol
; 51(3): 484-491, 2021 Mar 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33212499
15.
Management of Germ Cell Tumors During the Outbreak of the Novel Coronavirus Disease-19 Pandemic: A Survey of International Expertise Centers.
Oncologist
; 25(10): e1509-e1515, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32735386
16.
Adherence to abiraterone or enzalutamide in elderly metastatic castration-resistant prostate cancer.
Support Care Cancer
; 28(10): 4687-4695, 2020 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-31960124
17.
Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results.
J Transl Med
; 17(1): 296, 2019 08 29.
Artigo
Inglês
| MEDLINE | ID: mdl-31464635
18.
Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme.
BJU Int
; 123(1): 98-105, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29956884
19.
The effects of androgen deprivation therapy on the 18F-Chcoline uptake in prostate cancer patients undergoing neoadjuvant treatment.
Q J Nucl Med Mol Imaging
; 63(3): 278-283, 2019 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-27387380
20.
Activity and safety of metronomic cyclophosphamide in the modern era of metastatic castration-resistant prostate cancer.
Future Oncol
; 15(10): 1115-1123, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30887825